Literature DB >> 2822090

Inhibition of eukaryotic translation by analogues of messenger RNA 5'-cap: chemical and biological consequences of 5'-phosphate modifications of 7-methylguanosine 5'-monophosphate.

E Darzynkiewicz1, I Ekiel, P Lassota, S M Tahara.   

Abstract

New analogues of 7-methylguanosine 5'-monophosphate (m7GMP) were synthesized with modified 5'-phosphate moieties by replacement of -O with -H, -CH3, or -NH2. Additional analogues were synthesized with 8-methyl- or 8-aminoguanine base substitutions or ring-opened ribose (2',3'-diol). These compounds were analyzed by 1H and 31P NMR for solution conformation. In addition, they were also analyzed for biological activity as analogues of mRNA 5'-caps by competition as inhibitors of translation in reticulocyte lysate. Substitution of oxygen on the 5'-monophosphate moiety by -H and -CH3 diminished the activity of the cap analogue as a competitive inhibitor; however, replacement by -NH2 did not diminish the activity of the analogue as an inhibitor. It was inferred from this result that cap binding proteins require a hydrogen bond acceptor as opposed to having an exclusive requirement for a second anionic group on the alpha-phosphate moiety. Inhibition results obtained with C8-substituted m7GMP analogues indicated that the 8-amino derivative was a better inhibitor than the 8-methyl derivative of m7GMP. The former is primarily anti whereas the latter is primarily syn with respect to glycosidic bond conformation. This result further supports the model that the anti conformation is the preferred form of the cap structure for interaction with cap binding proteins. The 2',3'-diol derivative of m7GMP was inactive as an inhibitor of translation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822090     DOI: 10.1021/bi00388a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency.

Authors:  Ewa Grudzien; Janusz Stepinski; Marzena Jankowska-Anyszka; Ryszard Stolarski; Edward Darzynkiewicz; Robert E Rhoads
Journal:  RNA       Date:  2004-09       Impact factor: 4.942

2.  Emerging therapeutics targeting mRNA translation.

Authors:  Abba Malina; John R Mills; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

3.  Charge distribution in 7-methylguanine regarding cation-pi interaction with protein factor eIF4E.

Authors:  Katarzyna Ruszczynska; Krystyna Kamienska-Trela; Jacek Wojcik; Janusz Stepinski; Edward Darzynkiewicz; Ryszard Stolarski
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

4.  Light-mediated control of translational initiation of ribulose-1, 5-bisphosphate carboxylase in amaranth cotyledons.

Authors:  J O Berry; D E Breiding; D F Klessig
Journal:  Plant Cell       Date:  1990-08       Impact factor: 11.277

5.  Synthesis of N²-modified 7-methylguanosine 5'-monophosphates as nematode translation inhibitors.

Authors:  Karolina Piecyk; Richard E Davis; Marzena Jankowska-Anyszka
Journal:  Bioorg Med Chem       Date:  2012-06-10       Impact factor: 3.641

6.  Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap.

Authors:  Yifei Yan; Yuri Svitkin; Joseph M Lee; Martin Bisaillon; Jerry Pelletier
Journal:  RNA       Date:  2005-08       Impact factor: 4.942

7.  Beta-globin mRNAs capped with m7G, m2.7(2)G or m2.2.7(3)G differ in intrinsic translation efficiency.

Authors:  E Darzynkiewicz; J Stepinski; I Ekiel; Y Jin; D Haber; T Sijuwade; S M Tahara
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

8.  Synthesis of a fluorescent 7-methylguanosine analog and a fluorescence spectroscopic study of its reaction with wheatgerm cap binding proteins.

Authors:  J Ren; D J Goss
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

9.  Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP.

Authors:  Yan Jia; Ting-Lan Chiu; Elizabeth A Amin; Vitaly Polunovsky; Peter B Bitterman; Carston R Wagner
Journal:  Eur J Med Chem       Date:  2009-12-06       Impact factor: 6.514

10.  Novel "anti-reverse" cap analogs with superior translational properties.

Authors:  Jacek Jemielity; Tolvert Fowler; Joanna Zuberek; Janusz Stepinski; Magdalena Lewdorowicz; Anna Niedzwiecka; Ryszard Stolarski; Edward Darzynkiewicz; Robert E Rhoads
Journal:  RNA       Date:  2003-09       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.